Truist Financial Remains a Hold on Humana (HUM)

In a report released today, David S Macdonald from Truist Financial maintained a Hold rating on Humana (HUM – Research Report), with a price target of $355.00. The company’s shares closed yesterday at $315.98.

According to TipRanks, S Macdonald is a 5-star analyst with an average return of 12.5% and a 64.72% success rate. S Macdonald covers the Healthcare sector, focusing on stocks such as Humana, Option Care Health, and Cigna.

In addition to Truist Financial, Humana also received a Hold from Bank of America Securities’s Kevin Fischbeck in a report issued today. However, yesterday, Wells Fargo maintained a Buy rating on Humana (NYSE: HUM).

The company has a one-year high of $536.74 and a one-year low of $299.23. Currently, Humana has an average volume of 1.9M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Humana (HUM) Company Description:

Humana Inc. is a leading health insurance service provider in the United States. The company, through its Retail division, provides medicare benefits and state-based medicaid contracts, which are marketed on a retail basis to individuals. The Group and Specialty business offers employer group commercial fully-insured medical products and specialty health insurance benefits. Humana offers pharmacy solutions, provider services, home-based services, and clinical programs to the company’s health plan members as well as to third parties through the Healthcare Services segment.